151 related articles for article (PubMed ID: 34325089)
81. The absent kidney in 99Tcm-MAG3 renogram: a dramatic reversible consequence of contrast nephrotoxicity superimposed on renal obstruction.
Kayani I; Groves AM; Syed R; Nagabushan N; Pakzad F; Prvulovich EM; Bomanji JB
Br J Radiol; 2005 Apr; 78(928):349-52. PubMed ID: 15774598
[TBL] [Abstract][Full Text] [Related]
82. Screening with blood urea nitrogen before intravenous contrast.
Witting M; Kuo D
Am J Emerg Med; 2003 Oct; 21(6):494-6. PubMed ID: 14574660
[TBL] [Abstract][Full Text] [Related]
83. Metformin Reduces Renal Uptake of Radiotracers and Protects Kidneys from Radiation-Induced Damage.
Xiong C; Yin D; Li J; Huang Q; Ravoori MK; Kundra V; Zhu H; Yang Z; Lu Y; Li C
Mol Pharm; 2019 Feb; 16(2):808-815. PubMed ID: 30608713
[TBL] [Abstract][Full Text] [Related]
84. Gallium-68 and scandium-44 labelled radiotracers based on curcumin structure linked to bifunctional chelators: Synthesis and characterization of potential PET radiotracers.
Orteca G; Sinnes JP; Rubagotti S; Iori M; Capponi PC; Piel M; Rösch F; Ferrari E; Asti M
J Inorg Biochem; 2020 Mar; 204():110954. PubMed ID: 31838188
[TBL] [Abstract][Full Text] [Related]
85. Mass effect of injected dose in small rodent imaging by SPECT and PET.
Kung MP; Kung HF
Nucl Med Biol; 2005 Oct; 32(7):673-8. PubMed ID: 16243641
[TBL] [Abstract][Full Text] [Related]
86. Usefulness of 99mTc-hydroxymethylene-diphosphonate single photon emission computed tomography/computed tomography hybrid imaging in the study of tarsal tunnel syndrome.
Sánchez Aguilar M; García Jiménez R; García Gómez FJ; Borrego Dorado I
Reumatol Clin; 2016; 12(1):52-3. PubMed ID: 26026922
[No Abstract] [Full Text] [Related]
87. Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study.
Bodei L; Cremonesi M; Zoboli S; Grana C; Bartolomei M; Rocca P; Caracciolo M; Mäcke HR; Chinol M; Paganelli G
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):207-16. PubMed ID: 12552338
[TBL] [Abstract][Full Text] [Related]
88. Recent developments in peptide-based SPECT radiopharmaceuticals for breast tumor targeting.
Ahmadpour S; Hosseinimehr SJ
Life Sci; 2019 Dec; 239():116870. PubMed ID: 31525426
[TBL] [Abstract][Full Text] [Related]
89. A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours.
García-Garayoa E; Bläuenstein P; Blanc A; Maes V; Tourwé D; Schubiger PA
Eur J Nucl Med Mol Imaging; 2009 Jan; 36(1):37-47. PubMed ID: 18690434
[TBL] [Abstract][Full Text] [Related]
90. Dynamic and static small-animal SPECT in rats for monitoring renal function after 177Lu-labeled Tyr3-octreotate radionuclide therapy.
Melis M; de Swart J; de Visser M; Berndsen SC; Koelewijn S; Valkema R; Boerman OC; Krenning EP; de Jong M
J Nucl Med; 2010 Dec; 51(12):1962-8. PubMed ID: 21078795
[TBL] [Abstract][Full Text] [Related]
91. Nuclear Imaging of Glucose Metabolism: Beyond
Feng H; Wang X; Chen J; Cui J; Gao T; Gao Y; Zeng W
Contrast Media Mol Imaging; 2019; 2019():7954854. PubMed ID: 31049045
[TBL] [Abstract][Full Text] [Related]
92. Radiolabeled peptides in nuclear oncology: influence of peptide structure and labeling strategy on pharmacology.
Maecke HR
Ernst Schering Res Found Workshop; 2005; (49):43-72. PubMed ID: 15524210
[TBL] [Abstract][Full Text] [Related]
93. Improved in Vivo Targeting Capability and Pharmacokinetics of
Gao H; Luo C; Yang G; Du S; Li X; Zhao H; Shi J; Wang F
Bioconjug Chem; 2019 Jul; 30(7):2038-2048. PubMed ID: 31063685
[TBL] [Abstract][Full Text] [Related]
94. Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography.
Wilson AA; McCormick P; Kapur S; Willeit M; Garcia A; Hussey D; Houle S; Seeman P; Ginovart N
J Med Chem; 2005 Jun; 48(12):4153-60. PubMed ID: 15943487
[TBL] [Abstract][Full Text] [Related]
95. Radiopharmaceuticals for renal positron emission tomography imaging.
Szabo Z; Xia J; Mathews WB
Semin Nucl Med; 2008 Jan; 38(1):20-31. PubMed ID: 18096461
[TBL] [Abstract][Full Text] [Related]
96. Comparison of IgG and F(ab')2 fragments of bispecific anti-RCCxanti-DTIn-1 antibody for pretargeting purposes.
van Schaijk FG; Boerman OC; Soede AC; McBride WJ; Goldenberg DM; Corstens FH; Oosterwijk E
Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1089-95. PubMed ID: 15902440
[TBL] [Abstract][Full Text] [Related]
97. Radionuclide imaging of VEGFR2 in glioma vasculature using biparatopic affibody conjugate: proof-of-principle in a murine model.
Mitran B; Güler R; Roche FP; Lindström E; Selvaraju RK; Fleetwood F; Rinne SS; Claesson-Welsh L; Tolmachev V; Ståhl S; Orlova A; Löfblom J
Theranostics; 2018; 8(16):4462-4476. PubMed ID: 30214632
[TBL] [Abstract][Full Text] [Related]
98. Radiopharmaceuticals for Therapy.
Le D
J Nucl Med; 2017 May; ():. PubMed ID: 28546335
[No Abstract] [Full Text] [Related]
99. Efficiency of succinylated gelatin and amino acid infusions for kidney uptake reduction of radiolabeled αvβ6-integrin targeting peptides: considerations on clinical safety profiles.
Stangl S; Nguyen NT; Brosch-Lenz J; Šimeček J; Weber WA; Kossatz S; Notni J
Eur J Nucl Med Mol Imaging; 2024 May; ():. PubMed ID: 38717591
[TBL] [Abstract][Full Text] [Related]
100. Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m.
Bezverkhniaia E; Kanellopoulos P; Rosenström U; Tolmachev V; Orlova A
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
